Adjuvant Therapy Using Mistletoe Containing Drugs Boosts the T-Cell-Mediated Killing of Glioma Cells and Prolongs the Survival of Glioma Bearing Mice

Evidence-based Complementary and Alternative Medicine : ECAM
Sonja SchötterlUlrike Naumann

Abstract

Viscum album L. extracts (VE) are applied as complementary cancer therapeutics for more than one century. Extracts contain several compounds like mistletoe lectins (ML) 1-3 and viscotoxins, but also several minor ingredients. Since ML-1 has been described as one of the main active components harboring antitumor activity, purified native or recombinant ML-1 has been also used in clinical trials in the last years. The present study examined and compared the immunoboosting effects of three ML-1 containing drugs (the extract ISCADOR Qu, the recombinant ML-1 Aviscumine, and purified native ML-1) in the context of the T-cell mediated killing of glioma cells. Additionally we examined the possible underlying T-cell stimulating mechanisms. Using cocultures of immune and glioma cells, a PCR-based microarray, quantitative RT-PCR, and an antibody-based array to measure cytokines in blood serum, immunosupporting effects were determined. A highly aggressive, orthotopic, immunocompetent syngeneic mouse glioma model was used to determine the survival of mice treated with ISCADOR Qu alone or in combination with tumor irradiation and temozolomide (TMZ). Treatment of glioblastoma (GBM) cells with ISCADOR Qu that contains a high ML concentration, ...Continue Reading

References

Jun 21, 1996·The Journal of Biological Chemistry·A ItoY Mori
Jan 1, 1997·Immunologic Research·T W Behrens, D L Mueller
Dec 16, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G M Stein, P A Berg
Feb 21, 2002·Biochimica Et Biophysica Acta·Alexandre CoulonAndre Lopez
Sep 2, 2003·International Journal of Cancer. Journal International Du Cancer·Eduard ErnstMiriam Katharina Steuer-Vogt
Oct 21, 2003·International Immunology·James C ZimringJudith A Kapp
Nov 3, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Johannes MüthingJasna Peter-Katalinić
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
May 26, 2005·European Journal of Immunology·Markus H HammerPetra Reinke
Apr 29, 2009·The Journal of Experimental Medicine·Sotiria TzimaGeorge Kollias
Jan 19, 2010·Journal of Ethnopharmacology·José-Luis Ríos
May 15, 2010·European Journal of Clinical Pharmacology·Roman HuberChristoph H Gleiter
May 21, 2010·Forschende Komplementärmedizin = Research in Complementary Medicine·Sibylla Braedel-Ruoff
Feb 22, 2011·Journal of the American Society of Nephrology : JASN·Diane L Rosin, Mark D Okusa
Apr 13, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Heinz ZwierzinaHans Lentzen
Mar 21, 2012·TheScientificWorldJournal·Fotini M KouriAlexander H Stegh
May 29, 2012·Advances in Experimental Medicine and Biology·Cleo E RolleMaciej S Lesniak
Nov 8, 2012·Evidence-based Complementary and Alternative Medicine : ECAM·Oliver PodlechUlrike Naumann
Jul 31, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·W TrögerM Milićević
Aug 29, 2013·Cellular and Molecular Life Sciences : CMLS·Christian Ries
Sep 13, 2013·Oncology Reports·Ma Fátima G KlingbeilDécio S Pinto
Nov 28, 2013·The Journal of Experimental Medicine·Johannes Vom BergBurkhard Becher
Oct 8, 2014·Journal of Neuropathology and Experimental Neurology·Mushfika AhmadMichael Weller
Mar 31, 2015·Natural Product Research·Jolanta Nazaruk, Przemysław Orlikowski
Oct 19, 2016·Drug Discovery Today·Jiange QiuJianxiong Jiang
Dec 27, 2016·Biochemical Pharmacology·Davide ManganiPatrick Roth
Jan 20, 2017·International Journal of Oncology·Sonja SchötterlUlrike Naumann
Jan 1, 2014·3 Biotech·Seema Patel, Suryakanta Panda
Sep 16, 2017·ESMO Open·Dorte Schou NørøxeUlrik Lassen

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection
density gradient centrifugation
flow cytometry
FACS

Software Mentioned

GraphPad
Instat
Excel
ISCADOR
FloJo
JMP
ISCADOR Qu

Related Concepts

Related Feeds

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Related Papers

International Journal of Oncology
Sonja SchötterlUlrike Naumann
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
Carolyn BauerBernhard Przybilla
© 2022 Meta ULC. All rights reserved